[Other Specific Types of Diabetes and Exocrine Pancreatic Insufficiency (Update 2019)]

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2019 Apr 14

PMID 30980164

Citations 3

Authors

Susanne Kaser

Yvonne Winhofer-Stockl

Lili Kazemi-Shirazi

Sabine E Hofer

Helmut Brath

Harald Sourij

Greisa Vila

Heidemarie Abrahamian

Michaela Riedl

Raimund Weitgasser

Michael Resl

Martin Clodi

Anton Luger

Affiliations

Soon will be listed here.

Abstract

The heterogenous catagory "specific types of diabetes due to other causes" encompasses disturbances in glucose metabolism due to other endocrine disorders such as acromegaly or hypercortisolism, drug-induced diabetes (e. g. antipsychotic medications, glucocorticoids, immunosuppressive agents, highly active antiretroviral therapy (HAART)), genetic forms of diabetes (e. g. Maturity Onset Diabetes of the Young (MODY), neonatal diabetes, Down Syndrome, Klinefelter Syndrome, Turner Syndrome), pancreatogenic diabetes (e. g. postoperatively, pancreatitis, pancreatic cancer, haemochromatosis, cystic fibrosis), and some rare autoimmune or infectious forms of diabetes. Diagnosis of specific diabetes types might influence therapeutic considerations. Exocrine pancreatic insufficiency is not only found in patients with pancreatogenic diabetes but is also frequently seen in type 1 and long-standing type 2 diabetes.

Citing Articles

Long-Acting Injectable Antipsychotics-A Review on Formulation and In Vitro Dissolution.

Markowicz-Piasecka M, Kubisiak M, Asendrych-Wicik K, Kolodziejczyk M, Grzelinska J, Fabijanska M Pharmaceutics. 2024; 16(1).

PMID: 38258037 PMC: 10820045. DOI: 10.3390/pharmaceutics16010028.

[Other specific types of diabetes and exocrine pancreatic insufficiency (update 2023)].

Kaser S, Hofer S, Kazemi-Shirazi L, Festa A, Winhofer Y, Sourij H Wien Klin Wochenschr. 2023; 135(Suppl 1):18-31.

PMID: 37101022 PMC: 10133035. DOI: 10.1007/s00508-022-02123-x.

Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes.

Radlinger B, Ramoser G, Kaser S Curr Diab Rep. 2020; 20(6):18.

PMID: 32239341 PMC: 7113197. DOI: 10.1007/s11892-020-01304-0.

References

Tattersall R, FAJANS S . A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes. 1975; 24(1):44-53. DOI: 10.2337/diab.24.1.44. View

Slezak L, Andersen D . Pancreatic resection: effects on glucose metabolism. World J Surg. 2001; 25(4):452-60. DOI: 10.1007/s002680020337. View

Spyer G, Hattersley A, Sykes J, Sturley R, MacLeod K . Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am J Obstet Gynecol. 2001; 185(1):240-1. DOI: 10.1067/mob.2001.113127. View

FAJANS S, Bell G, Polonsky K . Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med. 2001; 345(13):971-80. DOI: 10.1056/NEJMra002168. View

Rathmann W, Haastert B, Icks A, Giani G, Hennings S, Mitchell J . Low faecal elastase 1 concentrations in type 2 diabetes mellitus. Scand J Gastroenterol. 2001; 36(10):1056-61. DOI: 10.1080/003655201750422657. View

Icks A, Haastert B, Giani G, Rathmann W . Low fecal elastase-1 in type I diabetes mellitus. Z Gastroenterol. 2001; 39(10):823-30. DOI: 10.1055/s-2001-17867. View

Luna B, Feinglos M . Drug-induced hyperglycemia. JAMA. 2001; 286(16):1945-8. DOI: 10.1001/jama.286.16.1945. View

Hardt P, Killinger A, Nalop J, Schnell-Kretschmer H, Zekorn T, Klor H . Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Pancreatology. 2002; 2(1):30-3. DOI: 10.1159/000049445. View

Stride A, Hattersley A . Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med. 2002; 34(3):207-16. View

10.

Hardt P, Hauenschild A, Nalop J, Marzeion A, Jaeger C, Teichmann J . High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology. 2003; 3(5):395-402. DOI: 10.1159/000073655. View

11.

Hardt P, Hauenschild A, Jaeger C, Teichmann J, Bretzel R, Kloer H . High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig Dis Sci. 2003; 48(9):1688-92. DOI: 10.1023/a:1025422423435. View

12.

Pearson E, Starkey B, Powell R, Gribble F, Clark P, Hattersley A . Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet. 2003; 362(9392):1275-81. DOI: 10.1016/S0140-6736(03)14571-0. View

13.

Nunes A, Pontes J, Rosa A, Gomes L, Carvalheiro M, Freitas D . Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus. Am J Gastroenterol. 2003; 98(12):2672-5. DOI: 10.1111/j.1572-0241.2003.08730.x. View

14.

Pearson E, Pruhova S, Tack C, Johansen A, Castleden H, Lumb P . Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia. 2005; 48(5):878-85. DOI: 10.1007/s00125-005-1738-y. View

15.

Stride A, Ellard S, Clark P, Shakespeare L, Salzmann M, Shepherd M . Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care. 2005; 28(7):1751-6. DOI: 10.2337/diacare.28.7.1751. View

16.

Milla C, Billings J, Moran A . Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care. 2005; 28(9):2141-4. DOI: 10.2337/diacare.28.9.2141. View

17.

Cavalot F, Bonomo K, Fiora E, Bacillo E, Salacone P, Chirio M . Does pancreatic elastase-1 in stools predict steatorrhea in type 1 diabetes?. Diabetes Care. 2006; 29(3):719-21. DOI: 10.2337/diacare.29.03.06.dc05-1389. View

18.

Feigerlova E, Pruhova S, Dittertova L, Lebl J, Pinterova D, Kolostova K . Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents. Eur J Pediatr. 2006; 165(7):446-52. DOI: 10.1007/s00431-006-0106-3. View

19.

Sarafidis P, Bakris G . Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control. QJM. 2006; 99(7):431-6. DOI: 10.1093/qjmed/hcl059. View

20.

Babenko A, Polak M, Cave H, Busiah K, Czernichow P, Scharfmann R . Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med. 2006; 355(5):456-66. DOI: 10.1056/NEJMoa055068. View